Clinical Trials Directory

Trials / Completed

CompletedNCT03133169

Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children

Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children in Assiut University Children Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
10 Years – 18 Years
Healthy volunteers
Accepted

Summary

The study will investigate the relation between erythrocyte glutamine/glutamate ratio and pulmonary hypertension risk in Egyptian thalassemic children in Assiut University Children Hospital

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTblood sampleblood sample for measuring liver and kidney function, CBC, ferritin level and erythrocyte glutamine level
DIAGNOSTIC_TESTTricuspid regurge velocityTricuspid regurge velocity will be measured by doppler echocardiography denoting the pulmonary hypertension risk in children

Timeline

Start date
2017-06-01
Primary completion
2019-08-25
Completion
2019-08-26
First posted
2017-04-28
Last updated
2019-08-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03133169. Inclusion in this directory is not an endorsement.

Erythrocyte Glutamine Level Relation to Pulmonary Hypertension Risk in Beta Thalassemia Major Children (NCT03133169) · Clinical Trials Directory